Cooper Companies (COO) Liabilities and Shareholders Equity (2009 - 2026)
Cooper Companies (COO) recorded quarterly Liabilities and Shareholders Equity of $12.5 billion in Q2 2026, little changed quarter-over-quarter from $12.4 billion in Q1 2026, and up 0.55% year-on-year from $12.4 billion in Q2 2025.
Cooper Companies (COO) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Cooper Companies has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $12.5 billion for Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 0.55% year-over-year to $12.5 billion; the trailing twelve-month figure through Apr 2026 stood at $49.7 billion (up 1.26% YoY), and the FY2025 full-year result was $12.4 billion, up 0.65% from the prior year.
- Liabilities and Shareholders Equity was $12.5 billion for Q2 2026 at Cooper Companies, roughly flat from $12.4 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $12.5 billion in Q2 2026 and troughed at $11.5 billion in Q4 2022.
- The 5-year median for Liabilities and Shareholders Equity is $12.0 billion (2024), against an average of $12.0 billion.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity jumped 30.72% in 2022, then fell 2.02% in 2023.
- Year by year, Liabilities and Shareholders Equity stood at $11.5 billion in 2022, then grew by 1.45% to $11.7 billion in 2023, then increased by 5.63% to $12.3 billion in 2024, then rose by 0.65% to $12.4 billion in 2025, then rose by 0.71% to $12.5 billion in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $12.5 billion in Q2 2026, $12.4 billion in Q1 2026, and $12.4 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 5.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 12.48 Bn |
| Jan 31, 2026 | 12.42 Bn |
| Oct 31, 2025 | 12.39 Bn |
| Jul 31, 2025 | 12.38 Bn |
| Apr 30, 2025 | 12.41 Bn |
| Jan 31, 2025 | 12.22 Bn |
| Oct 31, 2024 | 12.32 Bn |
| Jul 31, 2024 | 12.11 Bn |
| Apr 30, 2024 | 12.05 Bn |
| Jan 31, 2024 | 12.03 Bn |
| Oct 31, 2023 | 11.66 Bn |
| Jul 31, 2023 | 11.70 Bn |
| Apr 30, 2023 | 11.54 Bn |
| Jan 31, 2023 | 11.56 Bn |
| Oct 31, 2022 | 11.49 Bn |
| Jul 31, 2022 | 11.55 Bn |
| Apr 30, 2022 | 11.78 Bn |
| Jan 31, 2022 | 11.66 Bn |
| Oct 31, 2021 | 9.61 Bn |
| Jul 31, 2021 | 9.61 Bn |